BamA as a next-generation antibacterial target: mechanistic insights, inhibitor landscape, and rational drug design strategies
RSC Advances · 2026 · 16 (47) · 61346-61367
DOI: 10.1039/d6ra06788c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2026. Verfasst von Ahmed A Al-Karmalawy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt New Damietta 34518 Egypt akarmalawy@horus.edu.eg. Die Arbeit nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
BamA as a next-generation antibacterial target. Graphical abstract generated using Google Gemini (Nano Banana).
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt New Damietta 34518 Egypt akarmalawy@horus.edu.eg.
- Faculty of Pharmacy, Al-Ahliyya Amman University Amman Jordan.
ORCID-Profile: Ahmed A Al-Karmalawy
Zitieren
APA
Al-Karmalawy, A. A., Al Khatib, A. O., & Hawas, S. S. (2026). BamA as a next-generation antibacterial target: mechanistic insights, inhibitor landscape, and rational drug design strategies. RSC Advances, 16(47), 61346-61367. https://doi.org/10.1039/d6ra06788c
Vancouver
Al-Karmalawy AA, Al Khatib AO, Hawas SS. BamA as a next-generation antibacterial target: mechanistic insights, inhibitor landscape, and rational drug design strategies. RSC Advances. 2026;16(47):61346-61367. doi:10.1039/d6ra06788c
BibTeX
@article{AlKarmalawy2026,
author = {Al-Karmalawy, Ahmed A and Al Khatib, Arwa Omar and Hawas, Samia S},
title = {BamA as a next-generation antibacterial target: mechanistic insights, inhibitor landscape, and rational drug design strategies},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {47},
pages = {61346--61367},
doi = {10.1039/d6ra06788c}
}
EUVIMED